60.06
Schlusskurs vom Vortag:
$60.58
Offen:
$60.24
24-Stunden-Volumen:
1.15M
Relative Volume:
0.47
Marktkapitalisierung:
$9.14B
Einnahmen:
$3.46B
Nettoeinkommen (Verlust:
$-9.40M
KGV:
-249.83
EPS:
-0.2404
Netto-Cashflow:
$51.30M
1W Leistung:
-2.56%
1M Leistung:
+9.36%
6M Leistung:
+10.28%
1J Leistung:
+37.82%
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
BRKR
Bruker Corp
|
60.06 | 9.14B | 3.46B | -9.40M | 51.30M | -0.2404 |
|
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | Eingeleitet | Goldman | Sell |
| 2025-11-20 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-10 | Eingeleitet | UBS | Neutral |
| 2024-12-05 | Hochstufung | Goldman | Sell → Neutral |
| 2024-10-15 | Eingeleitet | Barclays | Overweight |
| 2024-09-30 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-21 | Eingeleitet | UBS | Buy |
| 2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Eingeleitet | Goldman | Sell |
| 2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-24 | Bestätigt | Needham | Strong Buy |
| 2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
| 2019-05-06 | Bestätigt | Needham | Strong Buy |
| 2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Hochstufung | UBS | Sell → Neutral |
| 2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Bestätigt | BTIG Research | Buy |
| 2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Bruker Corp (BRKR) executive Wolfgang Pusch discloses 10,154 Common Stock shares - Stock Titan
Bruker Corp (BRKR) Shares Surge 5.9% -- What GF Score of 86 Tells Investors - GuruFocus
Citi Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $60 - 富途牛牛
Bruker Corp strengthens its position in advanced scientific instruments as investors watch long-term - ad-hoc-news.de
Leerink Partners Forecasts Strong Price Appreciation for Bruker (NASDAQ:BRKR) Stock - MarketBeat
Bruker Corporation $BRKR Shares Sold by SG Americas Securities LLC - MarketBeat
Leerink raises Bruker stock price target to $70 on semiconductor strength - Investing.com
Bruker Corp highlights advanced scientific instruments as investors watch the stock - AD HOC NEWS
Bruker (NASDAQ:BRKR) Sparks Fresh Lab Tech Buzz - Kalkine Media
Bruker (NASDAQ:BRKR) Clears A Key Market Test - Kalkine Media
Spatial Genomics and Transcriptomics Market Size to Reach USD 1.90 Billion by 2035, Growing at a 12.23% CAGR | SNS Insider - GlobeNewswire Inc.
Guggenheim Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $70 - Moomoo
JPMorgan Maintains an “Overweight rating” on Bruker Corporation (BRKR) - Insider Monkey
Bruker Corp updates its scientific tools portfolio, shares tracked on NASDAQ - AD HOC NEWS
Bruker Introduces High-Throughput Sample-to-Answer Molecular Diagnostics System - Medical Product Outsourcing
Bruker (BRKR) Stock Trades Up, Here Is Why - Yahoo Finance
A Look at Bruker Corp (BRKR) After 4.2% Gain -- GF Value $62.64 vs Price $60.89 - GuruFocus
Trending Industry Today: Bruker Corp Leads Gains In Room-Temp Superconductors Stocks - Moomoo
BRKR Forecast — Price Target — Prediction for 2027 - TradingView
Bruker Is Maintained at Overweight by Barclays - Moomoo
Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $60 - 富途牛牛
Bruker Corp (BRKR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bruker Corp (BRKR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bruker Stocklong-term growth drivers in life science tools - AD HOC NEWS
Bruker Corp (BRKR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bruker Corp (BRKR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Fidelity Multi-Strategy Credit Fund's Bruker Corp(BRKRP.PFD) Holding History - GuruFocus
Bruker Gains 50.3% in a Year: What's Driving the Rally? - Yahoo Finance
Bruker-imec Project Advances Semiconductor Metrology Technique | Industry News | Jun 2026 - Photonics Spectra
Bruker Corp (BRKR) Stock Up 4.5% and Still Undervalued -- GF Sco - GuruFocus
Bruker Corporation $BRKR Stock Position Raised by Eversept Partners LP - MarketBeat
Bruker Corp (BRKR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bruker Corp (BRKR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bruker Corp (BRKR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bruker (BRKR) EVP exercises options, sells 2,000 pre-planned shares - Stock Titan
Inszone Insurance Services Acquires Sanford, Bruker & Banks, Inc., Adding Over a Century of Experience to Its Roster - Yahoo Finance
Bruker Corp (BRKR) Stock Up 4.4% and Still Undervalued -- GF Sco - GuruFocus
Broker Technologies (BRKR) files Form 144 to sell 2,000 shares (06/15/2026) - Stock Titan
Bruker Q2 2025 Earnings Preview - MSN
Bruker Corporation (NASDAQ: BRKR) files S-3 shelf for equity, debt and resale offerings - Stock Titan
Bruker Corp (BRKR) Stock Down 4.0% -- Now Undervalued? GF Score: 85/100 - GuruFocus
What Bruker (BRKR)'s Expanded Diagnostics and Energy-Research Tools Portfolio Means For Shareholders - Yahoo Finance
BRKR News | BRUKER CORP (NASDAQ:BRKR) - ChartMill
Bruker advances 4D proteomics, functional proteoform analysis and hybrid metabolomics at ASMS 2026 - Select Science
J.P. Morgan Maintains Bruker Corp(BRKR.US) With Buy Rating, Raises Target Price to $65 - 富途牛牛
Is Bruker Corporation (BRKR) A Good Stock To Buy Now? - Yahoo Finance
Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam - Yahoo Finance
BRKR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Legal & General Group Plc Sells 43,599 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker Corporation (NASDAQ:BRKR) Given Average Rating of "Hold" by Brokerages - MarketBeat
Bruker (BRKR) Up 37.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):